Impact of Inclusion of a Dog as Part of the Fibromyalgia Treatment Program on Patient's Physical and Mental Health Functioning - A Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Fibromyalgia
- Sponsor
- Mayo Clinic
- Enrollment
- 229
- Locations
- 2
- Primary Endpoint
- Change in Revised Fibromyalgia Impact Questionnaire (FIQR) score
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
In this study the investigators hypothesize that the presence of a Mayo Clinic certified therapy dog will provide additional benefits above typical therapy for patients suffering from fibromyalgia currently enrolled in the Mayo Clinic Fibromyalgia Program.
Detailed Description
The human animal bond refers an emotional relationship between animals and people. The purpose of this study is to evaluate whether the presence of a dog provide additional benefits above typical therapy for patients suffering from fibromyalgia and also to assess the emotional wellbeing state of the therapy dog.
Investigators
Arya B. Mohabbat, M.D.
PI
Mayo Clinic
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Change in Revised Fibromyalgia Impact Questionnaire (FIQR) score
Time Frame: Baseline to 1.5 day
The FIQR questionnaire consists of 21 questions in 3 domains. Each question has 11 boxes similar to a visual analog scale, rating the item from no difficulty to very difficult. To score the FIQR, the researcher must sum the answers for each domain. Then the function domain is divided by 3, the overall impact domain remains unchanged, and the symptom domain score is divided by 2. The resulting scores are added, and final score can range from 0 -100, with 0=no difficulty, and 100=great difficulty.
Secondary Outcomes
- Change in Pain Intensity Score (Numeric Rating Scale (NRS))(Baseline to 1.5 day)
- Change in Score for Fatigue, Anxiety, and Depression(Baseline to 1.5 day)